Family's mailing address filed with the SEC is Fairmount Ave, Philadelphia, PA, USA.
Over the last 6 years, insiders at Liquidia Corp have traded over 16,750,945$ worth of Liquidia Corp stock and bought 12,456,625 units worth 100,694,400$ . The most active insiders traders include Forest Baskett、Scott D Sandell、Peter J Barris. On average, Liquidia Corp executives and independent directors trade stock every 18 days with the average trade being worth of 1,467,274$. The most recent stock trade was executed by Russell Schundler on 30 August 2024, trading 2,344 units of LQDA stock currently worth 23,792$.
liquidia technologies is a biopharmaceutical company transforming the development of new therapies by precisely engineering drug particles. our proprietary print technology is a simple, elegant solution that solves common problems with drug delivery and efficacy. print technology is a scalable cgmp compliant process that creates particles and can apply to virtually any therapeutic area, molecule or route of administration. liquidia is bringing more efficient, controlled development capabilities to the industry while enhancing the safety and quality of products for patients. liquidia is advancing product candidates from its own pipeline. these initial product candidates, liq861 and liq865, apply the print technology to better drug delivery in inhaled and pain therapeutic areas, respectively. the print technology is also licensed with world-leading pharmaceutical companies that are developing future product candidates.
Liquidia Corp executives and other stock owners filed with the SEC include: